Previous 10 | Next 10 |
home / stock / xphyf / xphyf news
XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) director and CEO Hugh Rogers was a featured guest on two different video interviews. In both interviews, Rogers shared key information and updates about XPhyto, a bioscience accelerator focused on next-generation drug delivery,...
Last weekend, enthusiasts of plant medicine took part in the first-ever Psilocybin Cup . The event, which was organized by an incubation lab and consulting firm in Oakland, California, called Oakland Hyphae , had growers of magic mushrooms submit their mushrooms to the lab. This event ...
XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) today announced its commencement of a pilot project with its rapid COVID-19 PCR test ("Covid-ID Lab") in a point-of-care ("POC") setting in Germany. Covid-ID Lab was recently approved in Europe and offers the accuracy of a PCR test ...
Last week, the House in the state of Texas approved a measure that would decrease the criminal penalty for the possession of small amounts of cannabis, in addition to affording residents in the state who have been charged with cannabis possession the chance to expunge it from their records...
Pilot project includes point-of-care sample collection, PCR processing and final testing of workflow logistics Project is in cooperation with a German pharmacy currently running a COVID-19 test center Rapid results with high accuracy - 20-minute PCR run plus 5-minute detection pro...
Researchers still don’t know a lot about the novel coronavirus and how it attacks various organs in the body. However, among the biggest mysteries of this disease is how it causes oxygen levels in an individual’s body to become abnormally low. This condition, usually referred...
XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) was featured in a recent episode of Gamechangers LIVE , a podcast series that shines a spotlight on individuals who are gamechangers in their fields and shares perspective on their journeys, mindsets, struggles and successes in an ...
LOS ANGELES, May 06, 2021 (GLOBE NEWSWIRE) -- via InvestorWire — InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities, today announces that Hugh Rogers, CEO and Director of XPhyto Therapeutics Corp....
The legalization of marijuana is often considered to be a model for psychedelics. Thus far, marijuana has been legalized for both medical and recreational use in various nations across the globe and in numerous states in the United States. From the above, one can deduce that there are...
XPhyto Therapeutics Corp. recently announced it has entered into a distribution, storage and logistics agreement with a German distributor with an established network throughout Germany Germany holds promise due to regulations requiring mandatory weekly testing for its citizens; this ha...
News, Short Squeeze, Breakout and More Instantly...
XPhyto Therapeutics Corp Company Name:
XPHYF Stock Symbol:
OTCMKTS Market:
VANCOUVER, BC / ACCESSWIRE / October 3, 2023 / BioNxt Solutions Inc. (" BioNxt " or the " Company ") (CSE:BNXT)(OTCQB:XPHYF)(FSE:4XT), announces that Per Thoresen and Peter Damouni have resigned as directors of the Company. The Company would like to thank Mr. Thoresen and Mr. Damouni for their c...
VANCOUVER, BC / ACCESSWIRE / September 28, 2023 / BioNxt Solutions Inc. (" BioNxt " or the " Company ") (CSE:BNXT)(OTCQB:BNXTF)(FSE:4XT) is pleased to announce that, further to its news releases dated August 4 and August 28, 2023, the Company has closed the second tranche of its non-brokered pri...
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESSWIRE / August 4, 2023 / BioNxt Solutions Inc. (" BioNxt " or the " Company ") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is pleased to announce a non-brokered private placement of u...